Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study is to investigate the clinical efficacy of three types of nucleotide/nucleoside
analogues in treatment of HBV-related acute-on-chronic liver failure.